2025 - 2026
|
|
PresidentMartin Miner, MD Dr. Martin Miner is the founder and co-director of the Men’s Health Center at the Miriam Hospital in Providence, Rhode Island. He served as Chief of Family and Community Medicine for the Miriam Hospital, a teaching hospital of the Warren Alpert Medical School, from 2008 to 2018. The Men’s Health Center, under his leadership, was the first such center to open in the US. He is a clinical professor of family medicine and urology at the Warren Alpert Medical School of Brown University in Providence and has been charged with the development of a multidisciplinary Men’s Health Center within the Lifespan/Brown University system since 2008. |
|
|
Vice PresidentMichael Zitzmann, MD, PhD Professor Michael Zitzmann is specialised within the fields of andrology, endocrinology, diabetology and sexual medicine at the University Clinics of Muenster, Germany. Regarding patient care, he focusses on endocrinological andrology and patients with sexual disorders: boys with pubertal disorders up to aging men with a variety of sexual and metabolic problems seek his advice. Since more than 25 years, his research also focusses on the development of contraceptives for men. Since then, he continues to perform as principal investigator in many international studies, collaborating with WHO and other organisations. Michael Zitzmann is a member of international committees, journal editorial boards and is on the Educational Board of the European Association of Andrology (EAA) and the German Adiposity Foundation. He is on the Board of the European Society of Sexual Medicine (ESSM) and holds the status of a Fellow of the European Committee of Sexual Medicine (FECSM). Michael Zitzmann is Editor in Chief of the journal The Aging Male and is on the Board of the US-American Androgen Society. |
|
|
SecretaryFranck Mauvais-Jarvis, MD, PhD Dr. Franck Mauvais-Jarvis is a physician-scientist specializing in endocrinology, metabolism, and hormone therapy. He trained in leading endocrinology programs at Paris university hospitals and holds a PhD in Biochemistry and Molecular Biology from Paris. After completing postdoctoral training at the Joslin Diabetes Center and Harvard Medical School, he became an internationally recognized expert on the roles of estrogens, androgens, and biological sex in metabolism, diabetes, and obesity. Dr. Mauvais-Jarvis currently directs the Hormone Therapy Clinic for aging male and female veterans at the New Orleans VA Medical Center. He also leads the NIH-sponsored Center of Biomedical Research Excellence in Sex-Based Precision Medicine and heads the Hormones & Metabolism Discovery Research Laboratory. He previously led major federally funded research programs at Baylor College of Medicine, Northwestern University, and now Tulane University School of Medicine. He serves as principal investigator on multiple grants from the National Institutes of Health and the U.S. Department of Veterans Affairs. His research has been supported by the Juvenile Diabetes Research Foundation, the American Diabetes Association, the American Heart Association, the March of Dimes Foundation, the French Diabetes Association, Pfizer, and Boehringer-Ingelheim Pharmaceuticals, with total funding exceeding $25 million. Dr. Mauvais-Jarvis is the author of over 200 peer-reviewed publications, editor of two scientific books, and has delivered more than 160 invited lectures around the world. His scientific and clinical contributions have earned him election to the American Society for Clinical Investigation and the Association of American Physicians. |
|
|
TreasurerSandeep Dhindsa, MD Dr. Sandeep Dhindsa is Professor of Medicine (with tenure) and Chief of the Division of Endocrinology and Metabolism at Saint Louis University. He completed his medical schooling from All India Institute of Medical Sciences in New Delhi, India. He did residency in Internal medicine from State University of New York at Brooklyn and fellowship in Endocrinology from University at Buffalo, NY. His primary area of research is hypogonadism in men with obesity and diabetes. He has served as the primary investigator on a grant from the American Diabetes Association and co-investigator on a grant from NIH to elucidate the effects of hypogonadism in men with type 2 diabetes or obesity on insulin sensitivity and inflammation and the response to treatment with testosterone. |
|
|
Immediate Past PresidentAbdulmaged M. Traish, MBA, PhD Abdulmaged Traish earned a B.Sc., in Chemistry & Botany form the University of Tripoli, Tripoli, LIBYA in 1971 and a Ph.D., in Biochemistry from Boston University, Boston, MA in January of 1978. After two years of training as a postdoctoral Fellowship in the Department of Biochemistry at Boston University school of Medicine, he was appointed as an assistant research professor of Biochemistry. Professor Traish also earned Master of Business Administration (MBA) from Boston University School of Management in 1993. Since 1979, Dr. Traish was collaborating with faculty in the Urology Department and in 1996 he was promoted to full professor in the Department of Biochemistry and Department of Urology. Research Professor Traish pursued basic research, in the field of steroid biochemistry and physiology of reproductive and sexual medicine. His contributions to the field of sexual medicine include the development of experimental animal models to investigate the endocrine regulation of sexual arousal physiology and function in males and females and his pioneering work on the basic mechanisms of sex steroid hormones on erectile physiology. Professor Traish has been successful in procuring research funds from the National Institute of Health as well as from the Private Sector and was instrumental in the establishment of the institute for sexual medicine at Boston University school of Medicine. Dr. Traish is a researcher with renowned national and international reputation. |
|
|
Executive SecretaryAbraham Morgentaler, MD, FACS Abraham Morgentaler, MD was born in Montreal, Canada. He graduated from Harvard College in 1978, and Harvard Medical School in 1982. Dr. Morgentaler completed his residency in 1988 from the Harvard Program in Urology, and then joined the faculty of Beth Israel Deaconess Medical Center and Harvard Medical School. He is currently the Blavatnik Faculty Fellow in Health and Longevity at Harvard Medical School. Dr. Morgentaler is an international authority on men’s health and a pioneer in the treatment of testosterone deficiency in men. His research is credited for reversing the decades-old belief that testosterone therapy is risky for prostate cancer. Dr. Morgentaler has published over 200 scientific articles on testosterone, prostate cancer, male sexual dysfunction, and male infertility. His h-index is 60. |
|
|
Members-at-LargeJanine David, MD, MB, BCh, DRCOG, DFFP, MRCGP, FECSM Janine David is a GP partner and trainer in Porthcawl, South Wales, UK. She is also an associate specialist in andrology at The Princess of Wales Hospital, Bridgend, UK. She has a special interest in male and female sexual dysfunction, with a particular interest in testosterone deficiency and erectile dysfunction. She is medical director of Men’s Health Wales, founding member and chairman of The Primary Care Testosterone Advisory Group (PCTAG) and secretary of The British Society for Sexual Medicine (BSSM). She is a regular speaker both nationally and internationally. She is a Fellow of the European Committee for Sexual Medicine (FECSM) and a member of the Androgen Society. Audit, research and publication writing have been a large part of her career; her most recent work includes chapter contributions to “Men’s Health and the Primary Care Physician; Men's Health 4e. (2021). United States: CRC Press” and “Testosterone in cardiometabolic and other diseases, Edizioni Minerva Medica, 2022, ISBN: 978-88-5532-113-6”. She is also a co-author of the recently published British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice (World J Mens Health Published online Feb 22, 2023). She loves her Corgi - Basil and playing tennis in her spare time. |
|
|
Members-at-LargeAdrian S. Dobs, MD, MHS Adrian Sandra Dobs, MD, MHS, is Professor of Medicine and Oncology and Director of the Johns Hopkins Clinical Research Network of the Johns Hopkins Institute for Clinical and Translational Research (JHCRN). The JHCRN is a multi-institutional collaboration linking academic and community hospitals in the mid-Atlantic United States. Dr Dobs received her undergraduate degree from Cornell University, a medical degree from Albany Medical College, in New York, and completed an internship in internal medicine at Montefiore Hospital, Albert Einstein College of Medicine, in the Bronx, New York. She held a fellowship in endocrinology from Johns Hopkins University School of Medicine and earned a master in health sciences degree in cardiovascular epidemiology at the Johns Hopkins University Bloomberg School of Public Health. |
|
|
Members-at-LargeGeoffrey Hackett, MD Professor Geoffrey Hackett was a consultant in Urology at University Hospitals Birmingham Foundation trust from 1994 – 2020 and Professor of Sexual Medicine at Aston University Birmingham since 2017. He worked as a Consultant in Urology and Sexual Medicine at Spire Hospital, Little Aston, Birmingham from 1998- 2024 and at Newson Health Menopause Clinic in Stratford-on Avon from 2016-2020.. He was also as a primary care physician for 34 years from 1978-2012. Professor Hackett was Chairman of the British Society for Sexual Medicine from 2005–2007 and has been on the Scientific Committee of the European Society for Sexual Medicine (ESSM) from 2003–2009, Executive Committee of ESSM from 2015-2017 and ISSM 2009-2012. |
